Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial

Gary Middleton, Paul Silcocks, Trevor Cox, Juan Valle, Jonathan Wadsley, David Propper, Fareeda Coxon, Paul Ross, Srinivasan Madhusudan, Tom Roques, David Cunningham, Stephen Falk, Nick Wadd, Mark Harrison, Pippa Corrie, Tim Iveson, Angus Robinson, Karen McAdam, Martin Eatock, Jeff EvansCaroline Archer, Tamas Hickish, Angel Garcia-Alonso, Marianne Nicolson, William Steward, Alan Anthoney, William Greenhalf, Victoria Shaw, Eithne Costello, Dean Naisbitt, Charlotte Rawcliffe, Gemma Nanson, John Neoptolemos

Research output: Contribution to journal › Article › peer-review

183 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences